The Society for Immunotherapy of Cancer (SITC) hosted the "Combination Immunotherapy Resistance Workshop" with the purpose of bringing together immunotherapy experts from across academia, government, and industry to reach consensus on definitions of IO resistance to accelerate drug development. Consensus resistance definitions from the workshop have recently been published in the Journal for ImmunoTherapy of Cancer (JITC) via three manuscripts, with one focusing on resistance to immunotherapy combinations, another on immunotherapy in combination with chemotherapy, and the third highlighting immunotherapy in combination with targeted therapies.
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us